The Cooper Companies, Inc. (NYSE:COO) Director Gary S. Petersmeyer Sells 300 Shares

The Cooper Companies, Inc. (NYSE:COO – Get Rating) Director Gary S. Petersmeyer sold 300 shares of the stock in a transaction dated Monday, April 11th. The stock was sold at an average price of $410.55, for a total transaction of $123,165.00. The sale was disclosed in a filing with the SEC, which is available through this link.

Shares of NYSE:COO opened at $406.96 on Tuesday. The company’s fifty day moving average price is $404.71 and its 200-day moving average price is $406.14. The firm has a market capitalization of $20.06 billion, a price-to-earnings ratio of 21.59, a PEG ratio of 2.66 and a beta of 0.85. The Cooper Companies, Inc. has a one year low of $368.78 and a one year high of $463.59. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.02 and a quick ratio of 0.67.

Cooper Companies (NYSE:COO – Get Rating) last announced its quarterly earnings results on Thursday, March 3rd. The medical device company reported $3.24 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.10 by $0.14. Cooper Companies had a net margin of 31.00% and a return on equity of 9.89%. The business had revenue of $787.20 million during the quarter, compared to analysts’ expectations of $739.30 million. During the same quarter in the prior year, the company posted $3.17 EPS. The firm’s revenue for the quarter was up 15.7% compared to the same quarter last year. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 14.09 EPS for the current year.

Several hedge funds have recently made changes to their positions in the company. BlackRock Inc. lifted its holdings in Cooper Companies by 4.1% during the fourth quarter. BlackRock Inc. now owns 4,000,869 shares of the medical device company’s stock valued at $1,676,126,000 after purchasing an additional 158,358 shares in the last quarter. State Street Corp increased its position in Cooper Companies by 2.3% during the fourth quarter. State Street Corp now owns 2,167,499 shares of the medical device company’s stock valued at $908,052,000 after acquiring an additional 49,729 shares during the last quarter. Veritas Asset Management LLP grew its holdings in shares of Cooper Companies by 12.0% in the fourth quarter. Veritas Asset Management LLP now owns 2,001,678 shares of the medical device company’s stock worth $838,583,000 after purchasing an additional 214,700 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Cooper Companies by 35.7% in the third quarter. Invesco Ltd. now owns 1,585,683 shares of the medical device company’s stock worth $655,378,000 after purchasing an additional 417,077 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of Cooper Companies by 5.5% in the fourth quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,168,375 shares of the medical device company’s stock worth $489,479,000 after purchasing an additional 61,222 shares during the last quarter. Hedge funds and other institutional investors own 98.00% of the company’s stock.

Several analysts have commented on the stock. Guggenheim upgraded shares of Cooper Companies from a “neutral” rating to a “buy” rating and set a $495.00 target price on the stock in a report on Monday, January 3rd. Stephens raised their target price on shares of Cooper Companies from $430.00 to $500.00 and gave the company an “overweight” rating in a research note on Monday, March 7th. StockNews.com assumed coverage on shares of Cooper Companies in a research note on Thursday, March 31st. They issued a “hold” rating for the company. Piper Sandler lifted their price objective on shares of Cooper Companies from $490.00 to $500.00 in a research report on Friday, March 4th. Finally, Needham & Company LLC assumed coverage on Cooper Companies in a report on Friday. They set a “hold” rating for the company. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $469.00.

About Cooper Companies (Get Rating)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Further Reading